Back
Ultragenyx Pharmaceutical, Inc.
RARE
$14.56
0.41%
Overview
Ultragenyx Pharmaceutical Inc. is a biopharmaceutical company. The Company is focused on the identification, acquisition, development, and commercialization of novel products for the treatment of...
Open
$0.00
Prior close
$14.50
Today's high
$0.00
Today's low
$0.00
52 Week high
$39.89
52 Week low
$12.73
News
Zacks Investment Research • 19 hours ago • RARE
RARE Stock Up 13% on FDA Approval of Sanfilippo Syndrome Gene Therapy
Zacks Investment Research • 23 hours ago • RARE
Ultragenyx (RARE) Surges 12.6%: Is This an Indication of Further Gains?
Seeking Alpha • 1 day ago • RARE
Ultragenyx Pharmaceutical Inc. (RARE) Discusses FDA Approval of FAYUVI as First Treatment for Sanfilippo Syndrome Type A Transcript
GlobeNewsWire • 1 day ago • RARE
Ultragenyx Announces Approval of FAYUVI™ Gene Therapy, the First-Ever FDA-Approved Treatment for Sanfilippo Syndrome Type A (MPS IIIA)
Reuters • 1 day ago • RARE
US FDA approves Ultragenyx's gene therapy for rare disorder
